치과용 골이식재 시장 : 시장 규모, 점유율, 성장률, 산업 분석, 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of dental bone graft substitutes Market

The global dental bone graft substitutes market was valued at USD 328.14 million in 2025 and is projected to grow to USD 350.25 million in 2026. The market is expected to reach USD 612.03 million by 2034, exhibiting a CAGR of 7.23% during the forecast period (2026-2034).

North America dominated the global market with a 47.93% share in 2025, driven by a high number of dental implant procedures, rising cases of bone injuries, and strong product innovation.

Dental bone graft substitutes are natural or synthetic materials used to repair or regenerate damaged bone tissue in dental procedures. These products include allografts, synthetic bone substitutes, demineralized bone matrix (DBM), and xenografts, and are widely used in implant dentistry and periodontal treatments.

Market Overview & Growth Drivers

The rising prevalence of dental disorders is a key factor driving market growth. According to the World Health Organization (WHO), 514 million children suffer from primary tooth decay, while 2 million adults are affected by permanent tooth decay globally. Increasing cases of periodontal disease, dental fractures, and tooth loss have accelerated demand for dental implants, thereby increasing the need for bone graft substitutes.

Additionally, the introduction of advanced products, growing awareness among patients, and increased R&D investments are contributing to market expansion. Strategic collaborations, acquisitions, and funding initiatives are further supporting innovation and product adoption.

Although the market declined in 2020 due to COVID-19-related clinic closures and restricted procedures, recovery began in 2021 with reopening of dental practices, increasing tele-dentistry adoption, and rising implant surgeries. The positive growth trend is expected to continue through 2034.

Market Trends

Rise of 3D-Printed Synthetic Bone Grafts

One of the most significant trends is the adoption of 3D-printed synthetic bone graft substitutes. These grafts closely mimic natural bone structure and enable better integration and long-term outcomes. Technological advancements allow customized graft design tailored to individual patients.

For example, in December 2022, Desktop Metal received U.S. FDA approval for its CMFlex 3D-printed regenerative bone graft for dental use. Increasing regulatory approvals and technological innovations are expected to further strengthen this trend.

Market Growth Factors

Introduction of Advanced Bone Graft Substitutes

The growing number of dental implant procedures requiring jawbone stabilization has increased demand for innovative graft materials.

• In February 2024, Geistlich Pharma AG introduced vallos granules, a demineralized allograft for dental applications.
• In June 2023, RevBio received a USD 2 million NIH grant to advance its dental adhesive bone scaffold product.

Such developments are expected to accelerate product adoption globally.

Strategic Acquisitions & Partnerships

Acquisitions and collaborations are strengthening market penetration. For instance, Biocomposites acquired Artoss in June 2023, expanding its bone graft portfolio in dentistry. Partnerships between manufacturers and dental service organizations (DSOs) are also boosting accessibility and product distribution.

Restraining Factors

Despite strong growth prospects, challenges remain. Clinical limitations, concerns about disease transmission, immunogenicity, inadequate bone formation, and strict regulatory requirements can limit adoption. Additionally, limited reimbursement coverage in several countries increases out-of-pocket expenses for patients, potentially restricting demand.

Segmentation Analysis

By Product Type

The market is segmented into allografts, synthetic substitutes, demineralized bone matrix, and xenografts.

• The demineralized bone matrix (DBM) segment dominated in 2025 due to increasing implant procedures and advanced product launches.
• The synthetic bone graft substitutes segment is projected to hold a 58.62% share in 2026, driven by high biocompatibility, osteoconductivity, availability, and cost-effectiveness.

By Form

The market includes granules, putty, and others.

• The granules segment dominated with a 62.00% share in 2026, supported by superior osteogenesis properties and ease of storage.
• The "others" segment is expected to grow at a higher CAGR due to innovation in plugs and block forms.

By End-User

The market is segmented into solo practices, DSO/group practices, and others.

• Solo practices led the market in 2026 with a 60.18% share, owing to strong patient preference for personalized treatment.
• DSO/group practices are projected to grow at a higher CAGR due to increasing implant procedures and strategic collaborations.

Regional Insights

North America

North America recorded USD 156.88 million in 2025 and is projected to reach USD 167.86 million in 2026. The U.S. market alone is expected to reach USD 152.04 million in 2026. Strong innovation, FDA approvals, and high implant volumes support growth.

Europe

Europe held the second-largest market share.

• UK: USD 12.99 million by 2026
• Germany: USD 22.31 million by 2026

Strategic acquisitions and R&D investments are driving expansion.

Asia Pacific

Asia Pacific is projected to register the highest CAGR.

• Japan: USD 20.11 million by 2026
• China: USD 18.61 million by 2026
• India: USD 8.57 million by 2026

Growth is fueled by rising geriatric population and increasing dental disorder prevalence.

Latin America & Middle East & Africa

Growth in these regions is driven by improving healthcare infrastructure, growing awareness, and increasing medical tourism.

Competitive Landscape

Key players include ZimVie Inc., Medtronic, Geistlich Pharma AG, Institut Straumann AG, Envista, Dentsply Sirona, Henry Schein, NovaBone, BioHorizons, botiss biomaterials GmbH, and others.

These companies focus on R&D, product launches, acquisitions, and geographical expansion to strengthen their market positions.

Conclusion

The global dental bone graft substitutes market is poised for steady growth, expanding from USD 328.14 million in 2025 to USD 612.03 million by 2034, driven by increasing dental implant procedures, technological advancements such as 3D-printed grafts, and strong regional innovation. North America remains the dominant market, while Asia Pacific is emerging as the fastest-growing region. Despite reimbursement and clinical challenges, rising R&D investments and strategic collaborations are expected to ensure sustained market expansion through 2034.

Segmentation By Product Type

• Allograft
• Synthetic Bone Graft Substitutes
• Demineralized Bone Matrix
• Xenograft

By Form

• Granules
• Putty
• Others

By End-user

• Solo Practices
• DSO/ Group Practices
• Others

By Regin

• North America (By Product Type, Form, End-user, Country)
  • U.S.
  • Canada
• Europe (By Product Type, Form, End-user, Country/ Sub-region)
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Product Type, Form, End-user, Country/ Sub-region)
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Product Type, Form, End-user, Country/ Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, Form, End-user, Country/ Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East and Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Dental Disorders, By Key Countries/ Region, 2025
• 4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
• 4.3. New Product Launches, By Key Players
• 4.4. Impact of COVID-19 on the Market

5. Global Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Allograft
  • 5.1.2. Synthetic Bone Graft Substitute
  • 5.1.3. Demineralized Bone Matrix
  • 5.1.4. Xenograft
• 5.2. Market Analysis, Insights and Forecast - By Form
  • 5.2.1. Granules
  • 5.2.2. Putty
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Solo Practices
  • 5.3.2. DSO/Group Practices
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Allograft
  • 6.1.2. Synthetic Bone Graft Substitute
  • 6.1.3. Demineralized Bone Matrix
  • 6.1.4. Xenograft
• 6.2. Market Analysis, Insights and Forecast - By Form
  • 6.2.1. Granules
  • 6.2.2. Putty
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Solo Practices
  • 6.3.2. DSO/Group Practices
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Allograft
  • 7.1.2. Synthetic Bone Graft Substitute
  • 7.1.3. Demineralized Bone Matrix
  • 7.1.4. Xenograft
• 7.2. Market Analysis, Insights and Forecast - By Form
  • 7.2.1. Granules
  • 7.2.2. Putty
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Solo Practices
  • 7.3.2. DSO/Group Practices
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Allograft
  • 8.1.2. Synthetic Bone Graft Substitute
  • 8.1.3. Demineralized Bone Matrix
  • 8.1.4. Xenograft
• 8.2. Market Analysis, Insights and Forecast - By Form
  • 8.2.1. Granules
  • 8.2.2. Putty
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Solo Practices
  • 8.3.2. DSO/Group Practices
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. South Korea
  • 8.4.7. Rest of Asia Pacific

9. Latin America Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Allograft
  • 9.1.2. Synthetic Bone Graft Substitute
  • 9.1.3. Demineralized Bone Matrix
  • 9.1.4. Xenograft
• 9.2. Market Analysis, Insights and Forecast - By Form
  • 9.2.1. Granules
  • 9.2.2. Putty
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Solo Practices
  • 9.3.2. DSO/Group Practices
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Dental Bone Graft Substitutes Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Allograft
  • 10.1.2. Synthetic Bone Graft Substitute
  • 10.1.3. Demineralized Bone Matrix
  • 10.1.4. Xenograft
• 10.2. Market Analysis, Insights and Forecast - By Form
  • 10.2.1. Granules
  • 10.2.2. Putty
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Solo Practices
  • 10.3.2. DSO/Group Practices
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-Region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. ZimVie Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Institut Straumann AG
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Envista
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Dentsply Sirona.
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Henry Schein, Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Medtronic
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. BioHorizons
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. NovaBone (Halma)
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Geistlich Pharma AG
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. botiss biomaterials GmbH
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)
  • 11.2.11. curasan AG
    • 11.2.11.1. Overview
    • 11.2.11.2. Products & services
    • 11.2.11.3. SWOT Analysis
    • 11.2.11.4. Recent Developments
    • 11.2.11.5. Strategies
    • 11.2.11.6. Financials (Based on Availability)